Winging It Wednesday On Illegal Immigrants, Sebelius & Plan B
Today's edition of Winging It Wednesday featured only two panelists, Warren Caudle and Carol Ross. Mike Stagg was out due to illness.
The Two panelists were busy tackling the following issus:
- The Senate Banking Committee questioned another top official of the agency that oversees Fannie Mae and Freddie Mac ( Tuesday )yesterday. Federal Housing Finance Agency Inspector General Steve Linick testified before the panel that's concerned about how much the two government-sponsored mortgage bankers pay their executives and what they've doing to depend less on taxpayer money.
- Government figures show the number of people arrested for crossing into the U.S. illegally from Mexico is down. The numbers from U.S. Customs and Border Protection show a significant decrease in the last three years. Agents arrested more than 340-thousand illegal border crossers during fiscal year 2011, which ended September 30th.
- The U.S. Secretary of Health and Human Services says a drug company is welcome to re-apply for approval to market a morning-after pill to teen girls. Kathleen Sebelius made the announcement after her agency overruled an FDA recommendation that "Plan B" could be sold over the counter to girls younger than 17. Sebelius said Teva Pharmaceutical Industries can submit a new application after more testing.
- The Senate Banking Committee questioned another top official of the agency that oversees Fannie Mae and Freddie Mac ( Tuesday )yesterday. Federal Housing Finance Agency Inspector General Steve Linick testified before the panel that's concerned about how much the two government-sponsored mortgage bankers pay their executives and what they've doing to depend less on taxpayer money.
The U.S. Secretary of Health and Human Services says a drug company is welcome to re-apply for approval to market a morning-after pill to teen girls. Kathleen Sebelius made the announcement after her agency overruled an FDA recommendation that "Plan B" could be sold over the counter to girls younger than 17. Sebelius said Teva Pharmaceutical Industries can submit a new application after more testing.
More From News Talk 96.5 KPEL
